A generous collaboration with Prof. Uversky from University of South Florida has been very successful throughout these years. He is one of the pioneers of the concept behind Intrinsically Disordered Proteins (IDPs). His notable works include development of several predictors for IDP prediction, protein biophysics, etc. Prof. Uversky works with protein folding, misfolding, protein conformation diseases, and protein intrinsic disorder phenomenon. He combines experimental and bio-informatical approaches for his research. He has contributed immensely to the development of the disorder-function paradigm theory. His work particularly looks at the role of intrinsically disordered proteins in different diseases.

Prof. Mysorekar is the chief of Basic and Translational Research at Baylor College of Medicine. She is actively involved in understanding the cause behind recurrent UTI’s and also exploring possible infection angle involved in preterm births. As our collaborator, we are interested in her work with ZIKA virus. ZIKV is known for causing microcephaly in neonates, taking a heavy toll on human resource. Her work involves understanding how ZIKV crosses the placental barrier.

Prof. Vendruscolo is a professor of biophysics at University of Cambridge. He has contributed immensely to unravel the dynamics between protein folding, misfolding and aggregation. For more than the past fifteen years, his lab has employed both theoretical and experimental approaches to understand protein behaviour involved in neurodegenerative disorders. Dr. Vendruscolo has developed softwares that are widely used today for predicting protein aggregation.

Prof. Sanjeev is currently in Department of Bioinformatics at Alagappa University. His research expertise is in Computational Drug Design and Structural Bioinformatics approaches. His interest lies in the study of interactive small chemicals inhibitors with pathogenic viruses, specifically HIV-1, HTLV, HPV, ZIKA, and DENV, and exploration and designing of pharmacologically relevant molecules which can act as potent inhibitors of the various targets. We have worked in collaboration to identify inhibitor molecules for potential targets of ZIKA.